The Vertical Group news from FierceHealthFinance
News
OncoMed raises $93 million in second round financing extension
Cancer stem-cell start up OncoMed has raised $93 million in a second round financing extension, bringing its total to around $154 million. The company, which has raised $204 million to date, plans to... Read more...





